Concepedia

Raffael Nachbagauer

RN

Statistics

Publications

73

Citations

6.4K

H-Index

42

Active since

2011

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Moderna Therapeutics (United States)

University of Vienna

Program for Appropriate Technology in Health

Scripps Research Institute

Raffael Nachbagauer is an author at Icahn School of Medicine at Mount Sinai specializing in immunology, infectious diseases, and vaccinology.

ORCID

Publications per year

2011–2025

73

Publications

73

Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity

Susana V. Bardina, Paul Bunduc, Shashank Tripathi et al. · Science · 2017 · 536 citations · Full text

, , +17

A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice

Dorottya Laczkó, Michael J. Hogan, Sushila A. Toulmin et al. · Immunity · 2020 · 389 citations · Full text

, , +14

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

Raffael Nachbagauer, Jodi Feser, Abdollah Naficy et al. · Nature Medicine · 2020 · 358 citations

, , +14

A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice

Alec W. Freyn, Jamile Ramos da Silva, Victoria Rosado et al. · Molecular Therapy · 2020 · 310 citations · Full text

, , +17

Broadly protective human antibodies that target the active site of influenza virus neuraminidase

Daniel Stadlbauer, Xueyong Zhu, Meagan McMahon et al. · Science · 2019 · 286 citations · Full text

, , +16

1–5 of 73